Tag Archives: ALN-PCS
East Coast Biotech Roundup: X4, Rgenix, Alnylam, Intellia & More
What summer doldrums? It’s still not even Labor Day, yet the deals are already coming fast and furious. So fire up the grill and read on for some Series A rounds, crossover investments, data readouts, option-to-buy deals and more. —As Xconomy reported this week, a stealthy Cambridge, MA-based startup called X4 Pharmaceuticals raised a $37.5 […]
Posted in Boston, Boston blog main, National blog main, New York blog main, New York top stories | Tagged ALN-PCS, Alnylam Pharmaceuticals, Amgen, Amicus Therapeutics, aprepitant, Ariad Pharmaceuticals, Baxalta, Bristol-myers Squibb, Cholesterol, Columbia University, CRISPR-Cas9, deals, Emend, epidermolysis bullosa, Essential Tremor, Fibrosis, Gene editing, Genzyme, google, Henri Termeer, Intellia Therapeutics, Intercept Pharmaceuticals, Ivenix, Jeff Jonas, John Crowley, John Maraganore, Joslin Diabetes Center, Life Sciences, Masoud Tavazoie, Memorial Sloan-Kettering Cancer Center, Merck, Mozobil, obeticholic acid, Paula Ragan, PCSK9, plerixafor, Primary Biliary Cirrhosis, priority review voucher, Promedior, Regeneron Pharmaceuticals, Rgenix, RNAi, Rockefeller University, rolapitant, Roundups, Sage Therapeutics, Sanofi, ScioDerm, Shahram Seyedin-Noor, startups, Suzanne Bruhn, Tesaro, Tetraphase Pharmaceuticals, The Medicines Co., Varubi, VC, WuXi Healthcare Ventures, X4 Pharmaceuticals | Comments Off on East Coast Biotech Roundup: X4, Rgenix, Alnylam, Intellia & MoreAlnylam Gets First Hint of Effectiveness for RNAi Cholesterol-Lowering Drug
Alnylam Pharmaceuticals has been saying for a while that it needs hard data from clinical trials to prove its skeptics wrong, and today it’s coming out with an early hint of effectiveness with its RNA interference-based treatment for lowering cholesterol. Cambridge, MA-based Alnylam (NASDAQ: ALNY) is announcing today that it has gotten some encouraging results […]
Posted in Boston, Boston blog main, Boston top stories, National blog main | Tagged ALN-PCS, Alnylam Pharmaceuticals, Amgen, Biotech, Bloomberg News, Brigham & Women's Hospital, Bristol-myers Squibb, Cholesterol, Drugs, Heart Disease, IMS Health, Isis Pharmaceuticals, Life Sciences, Merck, PCSK9, RNA Interference, Roche, Sanofi, Statins, TTR Amyloidosis | 1 CommentAlnylam Looks to ASCO as First “Bell-Ringing” for RNAi Resurgence
When Cambridge, MA-based Alnylam (NASDAQ: ALNY) made its debut last year at the annual American Society of Clinical Oncology (ASCO) conference, it only had a pittance of safety data on its drug, which is designed to treat advanced solid tumors that have spread to the liver. At this year’s conference, which starts June 3 in Chicago, […]
Posted in Boston, Boston blog main, National blog main | Tagged ALN-PCS, ALN-TTR, ALN-VSP02, Alnylam, American Society of Clinical Oncology, ASCO, Biotech, cancer, Cubist, GlaxoSmithKline, John Maraganore, KSP, Life Sciences, Merck, Novartis, RNAi, Roche, Takeda, Tekmira, VEGF | 2 CommentsAlnylam Maps Out First Steps in ‘RNA Decade’
Alnylam Pharmaceuticals CEO John Maraganore had a snappy greeting ready for our first conversation of 2010. “Happy RNA Decade,” Maraganore said. For the sake of his Cambridge, MA-based company (NASDAQ: ALNY), Maraganore is wagering that this will be the decade in which scientific seeds of RNA-based therapies start to fulfill their potential. The decade-long vision […]
Posted in Boston, Boston blog main, National blog main | Tagged ALN-PCS, ALN-TTR, ALN-VSP, ALNRSV01, Alnylam Pharmaceuticals, Antibodies, Biotech, Cubist Pharmaceuticals, deals, Finances, Genzyme, John Maraganore, Life Sciences, MicroRNA, people, RNA Activation, RNA Interference | 2 CommentsArchives
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- December 2007
- November 2007
- October 2007
- September 2007
- August 2007
- July 2007
- June 2007
- May 2007
- April 2007
- March 2007
- January 2007
- December 2006
- November 2006
- October 2006
- September 2006
- August 2006
- July 2006
- June 2006
- April 2006
- March 2006
- February 2006
- January 2006
- December 2005
- October 2005
- September 2005
- August 2005
- July 2005
- June 2005
- May 2005
- April 2005
- March 2005
- February 2005
- January 2005
- December 2004
- September 2004
- June 2004
- May 2004
- March 2004
- February 2004
- January 2004
- December 2003
- June 2003
- May 2003
- March 9
Meta